Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT

Myelodysplastic syndromes (MDS) are the second common indication for an Allo-HCT. We compared the outcomes of 1414 matched sibling (MSD) with 415 haplo-identical donors (HD) transplanted with post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis between 2014 and 2017. ...

Saved in:
Bibliographic Details
Main Authors: Raj, Kavita (Author) , Eikema, Dirk-Jan (Author) , Sheth, Vipul (Author) , Koster, Linda (Author) , de Wreede, Liesbeth C. (Author) , Blaise, Didier (Author) , Di Grazia, Carmela (Author) , Koc, Yener (Author) , Potter, Victoria (Author) , Chevallier, Patrice (Author) , Lopez- Corral, Lucia (Author) , Wu, Depei (Author) , Mielke, Stephan (Author) , Maertens, Johan (Author) , Meijer, Ellen (Author) , Huynh, Anne (Author) , Passweg, Jakob (Author) , Luft, Thomas (Author) , Pérez-Simón, Jose Antonio (Author) , Ciceri, Fabio (Author) , Piekarska, Agnieszka (Author) , Hayri Ozsan, G. (Author) , Kröger, Nicolaus (Author) , Robin, Marie (Author) , Yakoub-Agha, Ibrahim (Author)
Format: Article (Journal)
Language:English
Published: 28 September 2022
In: Blood cancer journal
Year: 2022, Volume: 12, Issue: 9, Pages: 1-10
ISSN:2044-5385
DOI:10.1038/s41408-022-00729-y
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41408-022-00729-y
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41408-022-00729-y
Get full text
Author Notes:Kavita Raj, Dirk-Jan Eikema, Vipul Sheth, Linda Koster, Liesbeth C. de Wreede, Didier Blaise, Carmela Di Grazia, Yener Koc, Victoria Potter, Patrice Chevallier, Lucia Lopez- Corral, Depei Wu, Stephan Mielke, Johan Maertens, Ellen Meijer, Anne Huynh, Jakob Passweg, Thomas Luft, Jose Antonio Pérez-Simón, Fabio Ciceri, Agnieszka Piekarska, G. Hayri Ozsan, Nicolaus Kröger, Marie Robin and Ibrahim Yakoub-Agha
Description
Summary:Myelodysplastic syndromes (MDS) are the second common indication for an Allo-HCT. We compared the outcomes of 1414 matched sibling (MSD) with 415 haplo-identical donors (HD) transplanted with post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis between 2014 and 2017. ...
Item Description:Gesehen am 07.11.2023
Physical Description:Online Resource
ISSN:2044-5385
DOI:10.1038/s41408-022-00729-y